Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
Credit Suisse 31st Annual Healthcare Conference
A virtual presentation will be made live starting on Tuesday, November 8, 2022
Stifel 2022 Healthcare Conference
Fireside chat: Wednesday, November 16, 2022 at 10:20 am EST
Location: Lotte New York Palace Hotel, New York, NY
Jefferies London Healthcare Conference
Fireside chat: Thursday, November 17, 2022 at 3:15 pm GMT (10:15 am EST)
Location: The Waldorf Hilton, London, UK
A live webcast and archived replay of the fireside chats along with a replay of the pre-recorded presentation will be available on the investors section of www.vorbio.com.
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$0.65 |
| Daily Volume: | 122,512 |
| Market Cap: | US$80.950M |
March 20, 2025 January 08, 2025 December 27, 2024 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
